Clinical Trials Browser

Sinonasal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Rectal Malignant Neoplasms

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

Oropharyngeal Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Glioblastoma

HPV-Related Squamous Cell Carcinoma

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Oropharyngeal Neoplasms

Glioblastoma

Pathologic Complete Response, Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Nasopharyngeal Carcinoma

Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Rectal Neoplasms

Pancreatic Neoplasms

Hypopharyngeal Neoplasms

Hypopharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Uterine Cervical Dysplasia

Advanced Solid Tumors

Esophageal Squamous Cell Carcinoma

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Malignant Tumor of Lacrimal Drainage Structure

Esophageal Neoplasms

Chemoradiotherapy

Myelosuppression

Nasopharyngeal Carcinoma

Esophageal Neoplasms

Esophageal Neoplasms

Locally Advanced Hypopharyngeal Carcinoma

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Rectal Neoplasms

Uterine Cervical Neoplasms

Squamous Cell Carcinoma of Head and Neck

Uterine Cervical Neoplasms

Margins of Excision, Rectal Neoplasms

Esophageal Neoplasms

Rectal Neoplasms

Clinical Trials

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

G-CSF After Chemo-radiation in Patients With Glioblastoma

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

(NeoScorch HN)

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

PRISM

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

FOBEAR

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Morpheus

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

InDuRanS

Comparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

NORAD01

PANC

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

ARMADILLO

CONCERT

CROWD

Neoadjuvant Radiotherapy for Malignant Lacrimal Sac Tumors

CELAEC

Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy

Trilaciclib Prevents Myelosuppression With Chemoradiotherapy

GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

SILAR

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

HNC-SYSU-003

Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)

PelvEx II

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation